It was demonstrated lncRNA TMPO-AS1 potentially fosters LCN2 transcriptional activity by binding to TF E2F6, and thus, stimulates the progression of ovarian cancer (Zhao et al., 2020). This evidence concerns the gene E2F6 and ovarian carcinoma.